Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 206

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Focal cryotherapy for localized prostate cancer: a report from the national Cryo On‐Line Database (COLD) Registry

Ward, John F., Jones, J. Stephen · 2012 · BJU International

Abstract

Study Type – Therapy (cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Selective destruction of targeted prostate tissue is now technically feasible. Much has been theorized but little is known about the proper patient selection or treatment outcomes to determine if this organ preserving approach to prostate cancer has merit for further study and diffusion into wider practice. Herein we present the largest retrospective registry report of men treated with sub‐total prostate cryotherapy in order to begin to understand how this treatment is being applied despite the paucity of data. OBJECTIVES: To identify recent trends in focal cryotherapy from a prospectively maintained treatment registry. To describe treatment outcomes after uncontrolled application of focally ablative techniques within community practice. MATERIALS AND METHODS: We conducted an analysis of the COLD Registry to identify patients treated with partial gland prostate cryoablation between 1997 and 2007. Preoperative characteristics and postoperative cancer‐specific and functional outcomes were assembled for analysis. RESULTS: The COLD Registry contained information for 5853 patients and focal cryotherapy was the codified procedure in 1160 patients (19.8%). A dramatic increase in focal treatments was observed, from 46 in 1999 to 567 in 2005 ( P < 0.01). The biochemical recurrence‐free rate (ASTRO definition) at 36 months was 75.7%. Prostate biopsy, performed in 164/1160 of patients (14.1%), was positive in 43 (26.3%) of those suspected of cancer recurrence, but in only 3.7% (43/1160) of treated patients. Urinary continence (defined as use of 0 pads) was 98.4%. Maintenance of spontaneous erections was 58.1%. Prolonged urinary retention (>30 days) occurred in six (1.1%) patients. Rectourethral fistula was observed in one (0.1%) patient. CONCLUSIONS: Focal cryoablation is increasingly used for selected patients with prostate cancer. Oncological efficacy in the present series appears similar to that of whole‐gland cryoablation. The impact of focal cryoablation on urinary, sexual and bowel function appears to be less than that of radical therapies, although preservation of sexual function is not as high as might be expected.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-410x.2011.10578.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 206

Metadata

Authors
Ward, J. F., & Jones, J. S.
Venue
BJU International
Publisher
Wiley
Published
2011-10-28
Volume
109
Issue
11
Pages
1648-1654
ISSN
  • 1464-4096 (ISSN-L)
  • 1464-410X
OpenAlex
W1477951362
Cited by
206
References
1
FWCI
12.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Focal cryotherapy for localized prostate cancer: a report from the national Cryo On‐Line Database (COLD) Registry. https://app.cochat.ai/papers/10.1111/j.1464-410x.2011.10578.x
The paper
Ward, J. F., & Jones, J. S. (2012). Focal cryotherapy for localized prostate cancer: a report from the national Cryo On‐Line Database (COLD) Registry. BJU International. https://doi.org/10.1111/j.1464-410x.2011.10578.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.